Related Experiment Videos
[Activity of polymorphic N-acetyltransferase in epilepsy]
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1985
Summary
Slow N-acetyl transferase activity is more common in epilepsy patients, suggesting it may predispose individuals to the condition and indicate a more severe disease course. Acetylator activity could be a prognostic epilepsy marker.
Area of Science:
- Pharmacogenetics
- Clinical Biochemistry
- Neurology
Context:
- The activity of N-acetyl transferase (NAT) exhibits genetic polymorphism, leading to distinct 'fast' and 'slow' acetylator phenotypes in the population.
- Epilepsy is a complex neurological disorder with multifactorial causes, and genetic predispositions are increasingly recognized.
Purpose:
- To investigate the association between N-acetyl transferase (NAT) activity phenotypes and epilepsy in a cohort of 150 patients.
- To determine if slow acetylation is a risk factor for developing epilepsy or influences disease severity.
Summary:
- A study involving 150 epileptic patients and normal subjects revealed a significantly higher prevalence of slow acetylators among those with epilepsy.
- These findings indicate that slow N-acetyl transferase (NAT) activity may be a contributing factor to epilepsy development and progression.
- The study suggests that assessing polymorphic N-acetyl transferase (NAT) activity could serve as a prognostic indicator for epilepsy.
Impact:
- This research highlights the potential role of pharmacogenetics in understanding epilepsy etiology.
- Identifying slow acetylators as a risk group could inform future preventative strategies and personalized treatment approaches for epilepsy.
- The determination of N-acetyl transferase (NAT) activity may offer a novel prognostic criterion for epilepsy management.